Immunocore Holdings plc (IMCR)

Immunocore Holdings plc (IMCR) is a healthcare company (biotechnology) based in the United Kingdom. The share price is $27.91, down 3.36% on the day, which values the company at $1.44B. Price as of 17 Nov 2026, 17:37 UTC, from Yahoo Finance.

Key facts

Share price
$27.91−3.36% today
Market value
$1.44B
Funk Score
53/100
Against its own history
Well below its usual priceusual price $76.75
200-week average
$41.8433% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Immunocore Holdings plc in more detail

IMCR trades at -43.4× next year's expected earnings, 3.4× sales. Measured against its own history, the price is 64% below what its usual multiples would imply ($76.75) — well below its usual price. It sits 33% below its 200-week average of $41.84.

Its Funk Score is 53 out of 100 (financial strength 3.6, profitability 2.5, growth 10.0, value 5.0, each out of 10).

In its favour: Operating margin is expanding; More cash than debt. Worth checking: Altman Z in the distress zone; Share count keeps rising.

3 of the superinvestors tracked here hold IMCR, including Louis Bacon (0.2% of the portfolio), Andrew Spokes (0.1% of the portfolio), Primecap team (0.1% of the portfolio).

Superinvestors holding IMCR

3 of the investors tracked here report a position in their latest 13F filing.

Immunocore Holdings plc (IMCR): questions and answers

What is Immunocore Holdings plc's market cap?

Immunocore Holdings plc is valued at $1.44B at a share price of $27.91.

Is IMCR overvalued or undervalued?

Against its own history, IMCR is well below its usual price: the price is 64% below the $76.75 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is IMCR above its 200-week moving average?

No. IMCR is 33.3% below its 200-week average of $41.84. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Immunocore Holdings plc growing?

Over the last three fiscal years Immunocore Holdings plc's revenue grew 31.9% a year.

Does IMCR pay a dividend?

Immunocore Holdings plc does not currently pay a regular dividend.

Which famous investors own IMCR?

In their latest quarterly filings, Louis Bacon (0.2% of the portfolio), Andrew Spokes (0.1% of the portfolio), Primecap team (0.1% of the portfolio) hold IMCR. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Immunocore Holdings plc (IMCR) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/IMCR

Underlying data: Yahoo Finance; company filings with the SEC.